We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
McDonald's (MCD) to Launch Plant-Based Burger Test in Canada
Read MoreHide Full Article
McDonald’s Corp. (MCD - Free Report) recently announced its three-month trial of a new plant-based burger P.L.T., (Plant. Lettuce. Tomato.) in collaboration with Beyond Meat, in Canada. Notably, the plant-based burger will be priced at $6.49 CAD, excluding tax. McDonald’s lovers can avail this burger starting Sep 30, which will be sold across 28 restaurants in Southwestern Ontario.
The Chicago-based burger giant solely designed the new patty. McDonald’s believes that the P.L.T., made with Beyond Meat’s plant-based patty with a warm, soft, sesame seed bun and free from artificial flavors and preservatives, will deliver iconic taste to customers. Global tests like these are likely to drive innovation, enabling the company to stay laser-focused for further measures. Ann Wahlgren, McDonald's vice president of Global Menu Strategy, stated that “During this test, we're excited to hear what customers love about the P.L.T. to help our global markets better understand what's best for their customers.”
Innovation to Drive the Top Line
McDonald’s is the world’s largest chain of fast-food restaurants with presence in more than 38,000 locations over 100 countries. It has reached the billion-dollar brand status through sustained product innovation and geographic expansion.
Apart from sales-building initiatives, McDonald’s strategic transformation plan to drive growth, efforts to boost the domestic business through various digital initiatives and refranchising efforts bode well. In second-quarter 2019, global comps grew 6.5%, marking its 16th straight quarter of positive comps. Moreover, U.S comps were up 5.7% in the period.
The company aims at improving its focus on growing guest traffic, operational excellence, product innovation, offering a value menu and rolling out more limited-time offerings. Bacon roll breakfast sandwich and the Taste of America burgers LTO were also a success in the reported quarter.
Year to date, shares of this Zacks Rank #3 (Hold) company have gained 19.7%, underperforming the industry’s 26% growth.
Chipotle, Dunkin' and Restaurant brands have an impressive long-term earnings growth rate of 18.5%, 9.8% and 9.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
McDonald's (MCD) to Launch Plant-Based Burger Test in Canada
McDonald’s Corp. (MCD - Free Report) recently announced its three-month trial of a new plant-based burger P.L.T., (Plant. Lettuce. Tomato.) in collaboration with Beyond Meat, in Canada. Notably, the plant-based burger will be priced at $6.49 CAD, excluding tax. McDonald’s lovers can avail this burger starting Sep 30, which will be sold across 28 restaurants in Southwestern Ontario.
The Chicago-based burger giant solely designed the new patty. McDonald’s believes that the P.L.T., made with Beyond Meat’s plant-based patty with a warm, soft, sesame seed bun and free from artificial flavors and preservatives, will deliver iconic taste to customers. Global tests like these are likely to drive innovation, enabling the company to stay laser-focused for further measures. Ann Wahlgren, McDonald's vice president of Global Menu Strategy, stated that “During this test, we're excited to hear what customers love about the P.L.T. to help our global markets better understand what's best for their customers.”
Innovation to Drive the Top Line
McDonald’s is the world’s largest chain of fast-food restaurants with presence in more than 38,000 locations over 100 countries. It has reached the billion-dollar brand status through sustained product innovation and geographic expansion.
Apart from sales-building initiatives, McDonald’s strategic transformation plan to drive growth, efforts to boost the domestic business through various digital initiatives and refranchising efforts bode well. In second-quarter 2019, global comps grew 6.5%, marking its 16th straight quarter of positive comps. Moreover, U.S comps were up 5.7% in the period.
The company aims at improving its focus on growing guest traffic, operational excellence, product innovation, offering a value menu and rolling out more limited-time offerings. Bacon roll breakfast sandwich and the Taste of America burgers LTO were also a success in the reported quarter.
Year to date, shares of this Zacks Rank #3 (Hold) company have gained 19.7%, underperforming the industry’s 26% growth.
Key Picks
Better-ranked stocks worth considering in the same space include Chipotle Mexican Grill, Inc. (CMG - Free Report) , Dunkin' Brands Group, Inc. and Restaurant Brands International Inc. (QSR - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Chipotle, Dunkin' and Restaurant brands have an impressive long-term earnings growth rate of 18.5%, 9.8% and 9.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>